- Home
- KULR vs AMRN Comparison
KULR vs AMRN Comparison
Compare KULR & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KULR
- AMRN
- Stock Information
- Founded
- KULR 2013
- AMRN 1989
- Country
- KULR United States
- AMRN Ireland
- Employees
- KULR 52
- AMRN N/A
- Industry
- KULR Electrical Products
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- KULR Technology
- AMRN Health Care
- Exchange
- KULR Nasdaq
- AMRN Nasdaq
- Market Cap
- KULR 200.5M
- AMRN 216.0M
- IPO Year
- KULR N/A
- AMRN 1993
- Fundamental
- Price
- KULR $5.28
- AMRN $15.65
- Analyst Decision
- KULR Strong Buy
- AMRN Strong Sell
- Analyst Count
- KULR 2
- AMRN 1
- Target Price
- KULR $40.00
- AMRN $12.00
- AVG Volume (30 Days)
- KULR 2.0M
- AMRN 68.0K
- Earning Date
- KULR 08-14-2025
- AMRN 07-30-2025
- Dividend Yield
- KULR N/A
- AMRN N/A
- EPS Growth
- KULR N/A
- AMRN N/A
- EPS
- KULR N/A
- AMRN N/A
- Revenue
- KULR $12,977,975.00
- AMRN $219,361,000.00
- Revenue This Year
- KULR $89.99
- AMRN N/A
- Revenue Next Year
- KULR $97.50
- AMRN N/A
- P/E Ratio
- KULR N/A
- AMRN N/A
- Revenue Growth
- KULR 35.81
- AMRN N/A
- 52 Week Low
- KULR $1.64
- AMRN $7.08
- 52 Week High
- KULR $43.92
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- KULR 38.06
- AMRN 57.86
- Support Level
- KULR $5.07
- AMRN $14.57
- Resistance Level
- KULR $5.55
- AMRN $15.25
- Average True Range (ATR)
- KULR 0.34
- AMRN 0.63
- MACD
- KULR 0.04
- AMRN -0.01
- Stochastic Oscillator
- KULR 17.07
- AMRN 94.67
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.